Hvordan bør vi udnytte mulighederne for analyse af registre og sundhedsdata i fremtiden?

433 views
302 views

Published on

Published in: Science
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
433
On SlideShare
0
From Embeds
0
Number of Embeds
7
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Hvordan bør vi udnytte mulighederne for analyse af registre og sundhedsdata i fremtiden?

  1. 1. Hvordan bør vi udnytte mulighederne for analyse af registre og sundhedsdata i fremtiden? Lars Juhl Jensen
  2. 2. strukturerede data
  3. 3. Jensen et al., Nature Reviews Genetics, 2012
  4. 4. ustrukturerede data
  5. 5. tekstmining
  6. 6. computer
  7. 7. smart som en hund
  8. 8. ordbog
  9. 9. bivirkninger
  10. 10. lægemidler
  11. 11. Clozapine clozapi n clossapi n klozapin e chlosapi n chlosapi ne chlozapi n chlozapi ne klossapi n closapin e klozapi nklosapi n
  12. 12. kan det gavne patienter?
  13. 13. bivirkningsovervågning
  14. 14. Eriksson et al., Drug Safety, 2014 Drug introduction Drug discontinuationAdverse event Adverse eventNegative modifier Indication Pre-existing condition Adverse drug reaction Possible adverse drug reaction ADR of additional drug
  15. 15. Eriksson et al., Drug Safety, 2014 Drug introduction Drug discontinuationAdverse eventIdentification start Adverse eventNegative modifier Indication Pre-existing condition Adverse drug reaction Possible adverse drug reaction ADR of additional drug
  16. 16. Eriksson et al., Drug Safety, 2014 Drug introduction Drug discontinuation Adverse eventNegative modifier Indication Pre-existing condition Adverse drug reaction Possible adverse drug reaction Adverse event ADR of additional drug Identification start
  17. 17. Eriksson et al., Drug Safety, 2014 Drug introduction Drug discontinuation Adverse eventNegative modifier Indication Pre-existing condition Adverse drug reaction Possible adverse drug reaction Adverse event ADR of additional drug Identification start
  18. 18. statistik
  19. 19. nye bivirkninger
  20. 20. hyppighed
  21. 21. Eriksson et al., Drug Safety, 2014
  22. 22. heterogen IT infrastruktur
  23. 23. sygdomstrajektorier
  24. 24. Landspatientregistret
  25. 25. Jensen et al., Nature Reviews Genetics, 2012
  26. 26. dslige sygdomskorrelatione
  27. 27. trajektorier
  28. 28. Jensen et al., Nature Communications, 2014
  29. 29. trajektorienetværk
  30. 30. Jensen et al., Nature Communications, 2014
  31. 31. centrale diagnoser
  32. 32. Jensen et al., Nature Communications, 2014
  33. 33. confounding
  34. 34. alder og køn
  35. 35. Jensen et al., Nature Communications, 2014
  36. 36. livsstil
  37. 37. undersøgelsesbias
  38. 38. udfordringer
  39. 39. standardisering af data
  40. 40. løbende data opdatering
  41. 41. integration med hospitaler
  42. 42. Mange tak! Bivirkninger Robert Eriksson Thomas Werge Søren Brunak Sygdomstrajektorier Anders Bøck Jensen Tudor Oprea Pope Moseley Søren Brunak Tekstmining Peter Bjødstrup Jensen Robert Eriksson Henriette Schmock Francisco S. Roque Anders Juul Marlene Dalgaard Massimo Andreatta Sune Frankild Eva Roitmann Thomas Hansen Karen Søeby Søren Bredkjær Thomas Werge Søren Brunak

×